10x Insights
Loading account…

EQ/International Equity Index Portfolio

Index fundEquityOpen-end fund
EQ Advisors TrustHoldings as of Jun 30, 2026Filed Aug 25, 2026

Developed international stock index fund

As of its 2026 Q2 report, EQ/International Equity Index Portfolio held 699 positions with $2.29B in net assets. Its ten largest holdings made up 14.1% of the fund. Its share classes cost 0.47%–0.72% a year. Over the 12 months to May 2026, it returned 22.2%, with dividends reinvested. In 2026 Q2 it added 347 new positions and exited 847.

2026 Q2 holdings and allocationChanges are against the previous quarter, 2026 Q1
Expense ratio
0.72%
$72 a year for every $10,000 invested
0.47% – 0.72% across the 3 classes
$2.29B
The whole fund, all share classes
699 holdings
14.1%in the top 10
Weight held in the ten largest holdings
Top 25 hold 25.8%
Return, 1 year
+22.2%
With dividends, to May 2026
3 yr total +65.4% · 5 yr total +56.4%
What this fund is
Objective, as filed

Seeks to achieve a total return (before expenses) that approximates the total return performance of a composite index comprised of 40% DJ Euro-STOXX 50 Index, 25% FTSE 100 Index, 25% TOPIX Index, and 10% S&P/ASX 200 Index, including reinvestment of dividends, at a risk level consistent with that of the composite index.

Strategy, summarised

The fund tracks a composite index weighted 40% DJ EuroSTOXX 50, 25% FTSE 100, 25% TOPIX, and 10% S&P/ASX 200 through a sub-adviser that uses replication for the FTSE 100, EuroSTOXX 50, and S&P/ASX 200, though sampling may be employed in certain circumstances, while TOPIX holdings are selected through stratified sampling based on industry weightings, market capitalizations, and yields. Because the sub-adviser may sample rather than replicate the FTSE 100, EuroSTOXX 50, and S&P/ASX 200, and uses stratified sampling for TOPIX, the fund's returns may diverge from its composite benchmark.

What you own

per cent of the fund
CompanyWeightValue
ASML Holding NV
3.50%
$80.21M
HSBC Holdings plc
1.49%
$34.01M
Roche Holding AG
1.32%
$30.13M
Novartis AG
1.31%
$29.88M
AstraZeneca plc
1.29%
$29.48M
Nestle SA
1.21%
$27.57M
Siemens AG
1.09%
$24.87M
Shell plc
0.99%
$22.66M
Tokyo Electron Ltd.
0.99%
$22.58M
BHP Group Ltd.
0.97%
$22.10M
Showing 1–10 of 699 · the top 10 are 14.14% of the fund, the top 25 are 25.77%

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

The 200 largest of 699 holdings, with the share counts as filed, open with a free account.

What the fund is made of

Percentages are of fund net assets. Rounding, liabilities and short positions can make totals differ from 100%.

99.77%
of net assets
Stocks98.41%
Cash & short-term1.37%
Other0.00%
Derivatives-0.01%

The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.

Derivatives are shown at market value, not notional exposure.

How it has done

Total return, dividends reinvested · to May 2026

C000024598 share class · total returns with dividends reinvested

1 year
+22.18%
3 years
+65.36%
Cumulative, not per year
5 years
+56.43%
Cumulative, not per year
Largest decline in 3 years
-10.63%
From a previous high to a later low
Cumulative return, last three years· Jul 2023 – May 2026

Volatility over the last 12 months: 13.99%. Past returns are a record, not a forecast.

Jun 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.

Fees & fund details

EQ/International Equity Index Portfolio is a developed international equity index fund.

Asset class
Equity
Region
Developed international
Management
Index (passive)
Fund type
Open-end fund
Expense ratio, by class
0.47% – 0.72%
Portfolio turnover
5.00% a year · as of 2025 Q2

Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.

Turnover is how much of the portfolio was replaced in a year.

Classified from what the fund holds, not from its name · 2026 Q2. The summary is a paraphrase of the prospectus; the objective is verbatim.

What changed this quarter

2026 Q2 vs 2026 Q1

Positions that entered or left the fund since its previous filing. Positions that were only resized are not listed.

347 new· the largest 8

Roche Holding AG
Novartis AG
Nestle SA
ABB Ltd.
UBS Group AG
Novo Nordisk A/S
Cie Financiere Richemont SA
Zurich Insurance Group AG

847 exited· the largest 8

Scottish Mortgage Investment Trust plc
Toyota Industries Corp.
Diploma plc
Beazley plc
Weir Group plc (The)
ResMed, Inc.
IMI plc
St James's Place plc
Connected research

Understand how this fund fits with the rest.

Explore shared holdings, compare funds and follow their businesses with your connected AI:

  • “Where do my funds overlap — this fund, QQQ and the fund in my 401(k)?”
  • “How do this fund’s ten biggest holdings stack up against each other?”
  • “For my target-date fund, what’s the real stock-and-bond mix once you look through it?”
See how it works →All research tools with a subscription. Use your own AI account.